MNOVMediciNova, Inc.

$69M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$123,319

Gross Profit

-$38,957-31.6% margin

Operating Income

-$3M-2741.7% margin

Net Income

-$3M-2473.6% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-8.4%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$48M

Total Liabilities

$4M

Stockholders' Equity

$44M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$123,319	$0	—
Gross Profit	-$38,957	$0	—
Operating Income	-$3M	-$3M	-2.2%
Net Income	-$3M	-$3M	-6.9%

MNOV Q3 2025 Earnings — MediciNova, Inc. Revenue & Financial Results | Market Cap Arena